• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Sil­i­con Val­ley Bank shut­ters; Rare dis­ease tri­als can't find enough pa­tients; FDA ad­comm votes in fa­vor of Po­livy ...

3 years ago
Weekly

Re­pub­li­can sen­a­tors slam pro­posed ac­cel­er­at­ed ap­proval pay­ment re­forms

3 years ago
Pharma
FDA+

FDA will phase out 22 Covid-19 guid­ance doc­u­ments as emer­gency de­c­la­ra­tion ex­pires

3 years ago
Pharma
FDA+

FDA sched­ules ad­comms for En­ta­sis' an­timi­cro­bial treat­ment, In­ter­cep­t's NASH hope­ful

3 years ago
FDA+

GAO to FDA: Do more to en­cour­age drug man­u­fac­tur­ing in­no­va­tion

3 years ago
FDA+
Manufacturing

Am­gen delves in­to re­la­tion­ships and asth­ma with not­ed ther­a­pist and au­thor

3 years ago
Pharma
Marketing

Ei­sai projects $7B in sales by 2030 for new Alzheimer's drug

3 years ago
Pharma

Con­gress moves bill re­quir­ing de­clas­si­fi­ca­tion of Covid-19 ori­gins in­fo to Biden's desk

3 years ago
Coronavirus

Sil­i­con Val­ley Bank, which served bio and tech sec­tors, is shut down af­ter days of tur­moil

3 years ago
Pharma

Al­lo­ri­on rais­es $50M Se­ries B; AskBio gets a new CEO

3 years ago
News Briefing

Mod­er­na looks to the West Coast for lat­est ex­pan­sion

3 years ago
Pharma
Manufacturing

Pfiz­er's mi­graine nasal spray from Bio­haven notch­es ap­proval

3 years ago
Pharma
FDA+

Ver­tex heads to the clin­ic with a next-gen stem cell can­di­date for type 1 di­a­betes

3 years ago
R&D
FDA+

Up­dat­ed: Wor­ries over Sil­i­con Val­ley Bank rip­ple through tech and biotech star­tups, VCs

3 years ago
Financing
Deals

Ver­san­t's new im­munol­o­gy biotech San­ta Ana Bio snags Se­ries A with GV, TPG part­ners on board

3 years ago
Financing
Startups

Bio­gen looks to its bench to re­place chair­man Pa­padopou­los; Lil­ly, Ab­b­Vie gene ther­a­py part­ner makes CSO hire

3 years ago
Peer Review

Ole­ma On­col­o­gy to cut 25% of staff, says it will fo­cus on late-stage pipeline

3 years ago
People
R&D

FDA ad­comm votes 11-2 to ex­pand Roche's Po­livy la­bel in DL­B­CL

3 years ago
Pharma
FDA+

Biden bud­get wants to more than dou­ble num­ber of ne­go­ti­at­ed drugs un­der Medicare, and elim­i­nate he­pati­tis C

3 years ago
FDA+
Law

Eli Lil­ly asks ‘what if’ in first Moun­jaro con­sumer cam­paign for type 2 di­a­betes

3 years ago
Pharma
Marketing

Al­ny­lam ex­pands RNAi com­mer­cial­iza­tion deal in Eu­rope

3 years ago
Pharma
Marketing

Phar­ma mar­keters change the ad­ver­tis­ing chan­nel from broad­cast to stream­ing TV, me­dia ex­perts weigh in

3 years ago
Marketing

FDA makes rare 'mis­in­for­ma­tion' com­ment on Lu­ci­ra's EUA for its at-home Covid-19 and flu test

3 years ago
Pharma
FDA+

De­moc­rats look to cap in­sulin price at $20 per vial

3 years ago
Pharma
First page Previous page 376377378379380381382 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times